May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Moxie’s category mix pivoted away from Flower, where sales fell 80.28% year over year and 57.35% month over month, leaving Flower at 36.94% share despite the brand holding rank 47 in Ohio Flower. Edible expanded to 33.59% share on 252.67% year-over-year growth and 94.93% month-over-month growth, while Vapor Pens held 23.35% share with a 14.45% year-over-year decline but a 21.61% month-over-month lift. With Concentrates down 72.87% year over year and 44.21% month over month to 4.94% share, and Pre-Roll at 1.18% share despite a 101.26% year-over-year rise and a 17.10% month-over-month dip, the mix implies an active reweighting toward Edible and a stabilization attempt in Vapor Pens even as Flower retreats.
The shift carries positioning implications: the 48.46% year-over-year drop in average price to $17.20 paired with Edible’s 252.67% year-over-year surge suggests a volume-led strategy favoring lower price points and higher trial, while Flower’s 80.28% year-over-year contraction alongside a 57.35% month-over-month decline indicates reduced reliance on premium inhalables. Vapor Pens’ 21.61% month-over-month rise against a 14.45% year-over-year dip signals selective recovery potential, whereas Concentrates’ 44.21% month-over-month slide and 72.87% year-over-year drop point to strategic deprioritization. Net effect: Moxie is migrating toward accessible formats (notably Edible at 33.59% share) and away from legacy potency-led segments, which aligns short-term with price compression but risks long-term distinctiveness if Flower remains at rank 47 in Ohio without offsetting brand equity in inhalables.
Competitive Landscape
Moxie sits at rank #47 in OH Flower in May 2026, down 27 positions from #20 year over year and 16 spots below its February 2026 rank of #31; compared with its peak at #15 in July 2025, the current placement is 32 ranks lower and trails the top tier where Riviera Creek holds #1 despite a 2-place YoY drift to #2 earlier and a 10.1% YoY sales contraction, while RYTHM advanced to #2 after a 7-rank YoY climb with 49.2% YoY sales growth and Klutch Cannabis moved to #3 with a 16-rank YoY rise and 161.1% YoY sales growth; taken together, a 27-rank YoY slide and a 16-rank drop since February 2026 indicate Moxie is losing relative velocity as faster-accelerating competitors gain shelf priority.

Notable Products
Cherry Lemon Gummies 10-Pack (100mg) delivered the largest month-over-month surge at +168.5%, vaulting into rank 4, while Blueberry Blackberry Gummies 10-Pack (100mg) climbed +137.7% to rank 1. In contrast, Wingsuit (2.83g) fell -65.0% and slid to rank 5, and Strawberry Banana Gummies 10-Pack (100mg) declined -17.9% at rank 8. With six of the top ten SKUs in May 2026 coming from the Edible category and Tropical Mango Gummies 10-Pack (100mg) up +63.5% at rank 2, the mix points to Moxie shifting consumer pull and likely merchandising priority toward gummies over flower, with dollars concentrating in flavors that can scale quickly off promotional velocity.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







